Publication: Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria
Issued Date
1995-01-01
Resource Type
ISSN
18783503
00359203
00359203
Other identifier(s)
2-s2.0-0028884817
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.89, No.5 (1995), 523-527
Suggested Citation
R. N. Price, F. Nosten, E. Kassa Luxemburger, Am Kham, A. Brockman, T. Chongsuphajaisiddhi, N. J. White Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.89, No.5 (1995), 523-527. doi:10.1016/0035-9203(95)90094-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/17321
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria
Other Contributor(s)
Abstract
To compare the therapeutic efficacy of oral artesunate and artemether in combination with mefloquine for the treatment of mutidrug resistant malaria, a trial was conducted in 540 adults and children on the Thai-Myanmar border. Three regimens were compared: Artesunate (4 mg/kg/d for 3 d), artemether (4 mg/kg/d for 3 d), both in combination with mefloquine (25 mg/kg), and a single dose of mefloquine (25 mg/kg). The artesunate and artemether regimens gave very similar clinical and parasitological responses, and were both very well tolerated. There was no significant adverse effect attributable to the artemisinin derivatives. Fever and parasite clearance times with mefloquine alone were significantly longer (P < 0.001). After adjusting for reinfections the failure rates were 13 9% for the artesunate combination, 12 3% for the artemether combination and 49 2% for mefloquine alone (P < 0 .0001; relative risk 3 8 [95% confidence interval 2 6-5 4]). Mefloquine should no longer be used alone for the treatment of multidrug resistant falciparum malaria in this area. Three-day combination regimens with artesunate or artemether are well tolerated and more effective. © 1995 Oxford University Press.